Investigadores del grupo SIBIUMA de la Universidad de Málaga e IBIMA Plataforma BIONAND han logrado un avance clave para la comprensión y el tratamiento de las enfermedades raras.
Read moreEn su tesis doctoral realizada en IQS, el Dr. Endika Torres ha desarrollado y aplicado diferentes modelos de predicción para la generación de inhibidores duales contra las proteínas quinasa FGFR2 e...
Read moreLa administración de butirato en modelos de ratones, combinada con la inmunoterapia, alargó su supervivencia
Read moreLos resultados podrían informar el futuro diseño de enfoques terapéuticos específicos para mutaciones para mejorar las opciones de tratamiento en niños con tumores cerebrales derivados de FGFR1. ...
Read moreThe collaboration will validate the prognostic value of the NLRP3 biomarker, measured through ASC-specks using VIVA-ELISA® technology
Read more100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients
Read moreSafety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using...
Read moreThe new study shows that pericytes do not disappear, instead, they are reprogrammed. This dysfunction is regulated by a cytokine (a secreted protein) called TGF-β, which acts as a messenger between t...
Read moreMaite Solas has received an scholarship Consolidator Grant scholarship to study the role of brain metabolism in the early stages of the disease.
Read moreEl Instituto de Biología Molecular y Celular de Plantas identifica un compuesto que combina efectos para aumentar el contenido de vitamina E en las hojas sin modificar sus genes
Read moreThe U.S. multinational BioIVT, a global leader in the development of high-quality biological samples and research services for drug and diagnostic development, has acquired the Catalan company BeCytes...
Read moreProfessionals from Hospital Clínic-IDIBAPS are leading two projects in medical technology innovation and two in advanced drug and therapy development, which have received funding through the Strategi...
Read more